미용 병용요법 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Combination Therapies In Aesthetics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 7,267,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,613,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,359,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

이 보고서는 세계 미용 병용요법 시장을 조사 분석하여 시장 촉진요인, 동향, 기회, 촉진요인, 과제 등 주요 시장 역학에 대한 평가와 시장 구조에 대한 자세한 인사이트를 제공합니다.

목차

제1장 주요 요약

제2장 시장 소개

제3장 세계의 미용 병용요법 시장 분석 시나리오

• 시장과 예측
  • 시장 규모와 전년비 성장

제4장 시장 역학

• 거시경제 요인
• 성장 촉진요인
  • 공급측
  • 수요측
• 성장 억제요인
• 기회
• 예측요인 - 관련성과 영향
• 병용요법 최근의 진보

제5장 세계의 미용 병용요법 시장 분석과 예측 : 요법 유형별

• 소개
• BPS(Basis Point Share) 분석 : 요법 유형별
• 전년비 성장 예측 : 요법 유형별
• 시장 금액 예측 : 요법 유형별
  • BTx-A/피부 충전제
  • BTx-A/레이저
  • 레이저/외용제
  • 레이저/고주파
  • 피부 충전제/외용제
  • 기타
• 주목할 만한 동향
• 시장 매력 : 요법 유형별

제6장 세계의 미용 병용요법 시장 분석과 예측 : 용도별

• 소개
• BPS(Basis Point Share) 분석 : 용도별
• 전년비 성장 예측 : 용도별
• 시장 금액 예측 : 용도별
  • 제모
  • 문신 제거
  • 피부 재생
  • 흉터 제거
  • 기타
• 주목할 만한 동향
• 시장 매력 : 용도별

제7장 세계의 미용 병용요법 시장 분석과 예측 : 최종 용도별

• 소개
• BPS(Basis Point Share) 분석 : 최종 용도별
• 전년비 성장 예측 : 최종 용도별
• 시장 금액 예측 : 최종 용도별
  • 병원
  • 외래 수술 센터
  • 피부과 클리닉
• 주목할 만한 동향
• 시장 매력 : 최종 용도별

제8장 세계의 미용 병용요법 시장 분석과 예측 : 지역별

• BPS(Basis Point Share) 분석 : 지역별
• 전년비 성장 예측 : 지역별
• 시장 금액 예측 : 지역별
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
• 시장 매력 : 지역별

제9장 북미의 미용 병용요법 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석 : 국가별
  • 전년비 성장 예측 : 국가별
  • 주요 규제
• 시장 금액 예측 : 요법 유형별
  • BTx-A/피부 충전제
  • BTx-A/레이저
  • 레이저/외용제
  • 레이저/고주파
  • 피부 충전제/외용제
  • 기타
• 시장 금액 예측 : 용도별
  • 제모
  • 문신 제거
  • 피부 재생
  • 흉터 제거
  • 기타
• 시장 금액 예측 : 최종 용도별
  • 병원
  • 외래 수술 센터
  • 피부과 클리닉
• 시장 금액 예측 : 국가별
  • 미국
  • 캐나다
• 시장 매력 분석
  • 요법 유형별
  • 용도별
  • 최종 용도별
  • 국가별
• 주목할 만한 동향
• 성장 촉진요인과 억제요인 : 영향 분석

제10장 라틴아메리카의 미용 병용요법 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석 : 국가별
  • 전년비 성장 예측 : 국가별
  • 주요 규제
• 시장 금액 예측 : 요법 유형별
  • BTx-A/피부 충전제
  • BTx-A/레이저
  • 레이저/외용제
  • 레이저/고주파
  • 피부 충전제/외용제
  • 기타
• 시장 금액 예측 : 용도별
  • 제모
  • 문신 제거
  • 피부 재생
  • 흉터 제거
  • 기타
• 시장 금액 예측 : 최종 용도별
  • 병원
  • 외래 수술 센터
  • 피부과 클리닉
• 시장 금액 예측 : 국가별
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
• 시장 매력 분석
  • 요법 유형별
  • 용도별
  • 최종 용도별
  • 국가별
• 주목할 만한 동향
• 성장 촉진요인과 억제요인 : 영향 분석

제11장 유럽의 미용 병용요법 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석 : 국가별
  • 전년비 성장 예측 : 국가별
  • 주요 규제
• 시장 금액 예측 : 요법 유형별
  • BTx-A/피부 충전제
  • BTx-A/레이저
  • 레이저/외용제
  • 레이저/고주파
  • 피부 충전제/외용제
  • 기타
• 시장 금액 예측 : 용도별
  • 제모
  • 문신 제거
  • 피부 재생
  • 흉터 제거
  • 기타
• 시장 금액 예측 : 최종 용도별
  • 병원
  • 외래 수술 센터
  • 피부과 클리닉
• 시장 금액 예측 : 국가별
  • 영국
  • 프랑스
  • 독일
  • 이탈리아
  • 스페인
  • 러시아
  • 기타 유럽
• 시장 매력 분석
  • 요법 유형별
  • 용도별
  • 최종 용도별
  • 국가별
• 주목할 만한 동향
• 성장 촉진요인과 억제요인 : 영향 분석

제12장 아시아태평양의 미용 병용요법 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석 : 국가별
  • 전년비 성장 예측 : 국가별
  • 주요 규제
• 시장 금액 예측 : 요법 유형별
  • BTx-A/피부 충전제
  • BTx-A/레이저
  • 레이저/외용제
  • 레이저/고주파
  • 피부 충전제/외용제
  • 기타
• 시장 금액 예측 : 용도별
  • 제모
  • 문신 제거
  • 피부 재생
  • 흉터 제거
  • 기타
• 시장 금액 예측 : 최종 용도별
  • 병원
  • 외래 수술 센터
  • 피부과 클리닉
• 시장 금액 예측 : 국가별
  • 일본
  • 중국
  • 인도
  • 호주·뉴질랜드
  • ASEAN
  • 기타 아시아태평양
• 시장 매력 분석
  • 요법 유형별
  • 용도별
  • 최종 용도별
  • 국가별
• 주목할 만한 동향
• 성장 촉진요인과 억제요인 : 영향 분석

제13장 중동 및 아프리카의 미용 병용요법 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석 : 국가별
  • 전년비 성장 예측 : 국가별
  • 주요 규제
• 시장 금액 예측 : 요법 유형별
  • BTx-A/피부 충전제
  • BTx-A/레이저
  • 레이저/외용제
  • 레이저/고주파
  • 피부 충전제/외용제
  • 기타
• 시장 금액 예측 : 용도별
  • 제모
  • 문신 제거
  • 피부 재생
  • 흉터 제거
  • 기타
• 시장 금액 예측 : 최종 용도별
  • 병원
  • 외래 수술 센터
  • 피부과 클리닉
• 시장 금액 예측 : 국가별
  • GCC 국가
  • 남아프리카공화국
  • 북아프리카
  • 기타 중동 및 아프리카
• 시장 매력 분석
  • 요법 유형별
  • 용도별
  • 최종 용도별
  • 국가별
• 주목할 만한 동향
• 성장 촉진요인과 억제요인 : 영향 분석

제14장 경쟁 상황

• 경쟁 대시보드
• 시장 점유율 분석 : 기업별(2024년)
• 기업 개요(상세 - 개요, 재무, 전략, 최근의 동향)
  • Alma Lasers Ltd.
  • Lumenis Ltd.
  • Cynosure Inc.
  • Valeant Pharmaceutical International, Inc.
  • Galderma S.A.
  • Anika Therapeutics, Inc.
  • Speciality European Pharma
  • Merz Pharma GmbH & Co. KGaA
  • Cutera, Inc
  • Allergan
  • Syneron Medical Ltd

제15장 사용되는 가정과 두문자어

제16장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for combination therapies in aesthetics. This report provides an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, offering a detailed overview of the market structure. This research publication presents exclusive data and insights projecting the growth trajectory of the global combination therapies in aesthetics market from 2024 to 2031.

Key Insights:

• Combination Therapies in Aesthetics Market Size (2024E): US$3491 Mn
• Projected Market Value (2031F): US$5,829.6 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 7.6%

Combination Therapies in Aesthetics Market - Report Scope:

Combination therapies in aesthetics integrate various treatments, such as injectables, laser therapy, and topical treatments, to achieve optimal results for skin rejuvenation, contouring, and anti-aging. These therapies enhance treatment outcomes by leveraging the synergies of different modalities, addressing multiple aesthetic concerns in one regimen. This market caters to a wide range of aesthetic applications, including facial contouring, body shaping, and wrinkle reduction. Market growth is driven by the rising demand for minimally invasive aesthetic procedures, advancements in therapeutic combinations, and the increasing emphasis on personalized aesthetic care.

Market Growth Drivers:

The global market for combination therapies in aesthetics is driven by several factors, including the growing preference for non-surgical procedures that deliver effective results with minimal downtime. The desire for natural-looking aesthetic outcomes is encouraging the use of multiple, synergistic therapies. Additionally, advancements in laser technology, fillers, and skin care formulations are fueling the adoption of combination therapies. The increasing popularity of customized aesthetic solutions among a diverse client base, coupled with the influence of social media, is further propelling market growth.

Market Restraints:

Despite its growth potential, the combination therapies in aesthetics market faces challenges, such as high procedure costs and regulatory complexities. The need for skilled practitioners to administer these treatments effectively limits market expansion in some regions. Additionally, safety concerns and the potential side effects associated with combination therapies can impact patient acceptance and regulatory approval processes.

Market Opportunities:

The combination therapies in aesthetics market presents substantial growth opportunities driven by technological advancements and evolving consumer preferences. Innovations in multi-modality devices, customized formulations, and minimally invasive techniques are expanding treatment options. Furthermore, the growing demand for anti-aging solutions in the aging population provides an avenue for market players to introduce targeted therapies. Strategic collaborations between technology developers, aesthetic clinics, and healthcare providers can facilitate market penetration and support consumer education.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the combination therapies in aesthetics market globally?
• Which treatment combinations are gaining traction across different aesthetic applications?
• How are technological advancements influencing the adoption of combination therapies in aesthetics?
• Who are the key players in the combination therapies in aesthetics market, and what strategies are they implementing to remain competitive?
• What emerging trends and future prospects are shaping the global combination therapies in aesthetics market?

Competitive Intelligence and Business Strategy:

Leading players in the global combination therapies in aesthetics market, including Allergan, Galderma, and Merz Pharmaceuticals, are focusing on product innovation, clinical partnerships, and targeted marketing strategies to stay competitive. These companies invest heavily in R&D to develop new combination treatments and deliver safe, effective aesthetic outcomes. Collaborations with aesthetic clinics, dermatologists, and influencers are instrumental in broadening consumer reach and enhancing technology adoption. Additionally, an emphasis on personalized care and improved patient experience is helping these players cater to a diverse and growing aesthetic market.

Key Companies Profiled:

• Alma Lasers Ltd.
• Lumenis Ltd.
• Cynosure Inc.
• Valeant Pharmaceutical International, Inc.
• Galderma S.A.
• Anika Therapeutics, Inc.
• Speciality European Pharma
• Merz Pharma GmbH & Co. KGaA
• Cutera, Inc
• Allergan
• Syneron Medical Ltd

Market Taxonomy

By Therapy Type

• BTx-A/Dermal Filler
• BTx-A/Laser
• Laser/Topical Drug
• Laser/Radiofrequency
• Dermal Filler/Topical Drug

By Application Type

• Hair Removal
• Tattoo Removal
• Skin Resurfacing
• Scar Removal

By End User

• Hospitals
• Ambulatory Surgical Centers
• Dermatology Clinics

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Table of Contents

1. Executive Summary

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy

3. Global Aesthetics Combination Therapy Market Analysis Scenario

• 3.1. Market Size (US$ Mn) and Forecast
  • 3.1.1. Market Size and Y-o-Y Growth
  • 3.1.2. Absolute $ Opportunity

4. Market Dynamics

• 4.1. Macro-economic Factors
• 4.2. Drivers
  • 4.2.1. Supply Side
  • 4.2.2. Demand Side
• 4.3. Restraints
• 4.4. Opportunity
• 4.5. Forecast Factors - Relevance and Impact
• 4.6. Recent Advances in Combination Therapies

5. Global Aesthetics Combination Therapy MarketAnalysis and Forecasts, By Therapy Type

• 5.1. Introduction
• 5.2. Basis Point Share (BPS) Analysis By Therapy Type
• 5.3. Y-o-Y Growth Projections By Therapy Type
• 5.4. Market Value Forecast By Therapy Type, 2024-2031
  • 5.4.1. BTx-A/Dermal Filler
  • 5.4.2. BTx-A/Laser
  • 5.4.3. Laser/Topical Drug
  • 5.4.4. Laser/Radiofrequency
  • 5.4.5. Dermal Filler/Topical Drug
  • 5.4.6. Others
• 5.5. Prominent Trends
• 5.6. Market Attractiveness By Therapy Type

6. Global Aesthetics Combination Therapy Market Analysis and Forecasts, By Application

• 6.1. Introduction
• 6.2. Basis Point Share (BPS) Analysis By Application
• 6.3. Y-o-Y Growth Projections By Application
• 6.4. Market Value Forecast By Application, 2024-2031
  • 6.4.1. Hair Removal
  • 6.4.2. Tattoo Removal
  • 6.4.3. Skin Resurfacing
  • 6.4.4. Scar Removal
  • 6.4.5. Others
• 6.5. Prominent Trends
• 6.6. Market Attractiveness By Application

7. Global Aesthetics Combination Therapy Market Analysis and Forecasts, By End Use

• 7.1. Introduction
• 7.2. Basis Point Share (BPS) Analysis By End Use
• 7.3. Y-o-Y Growth Projections By End Use
• 7.4. Market Value Forecast By End Use, 2024-2031
  • 7.4.1. Hospitals
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Dermatology Clinics
• 7.5. Prominent Trends
• 7.6. Market Attractiveness By End Use

8. Global Aesthetics Combination Therapy Market Analysis and Forecasts, By Region

• 8.1. Basis Point Share (BPS) Analysis By Region
• 8.2. Y-o-Y Growth Projections By Region
• 8.3. Market Value Forecast By Region
  • 8.3.1. North America
  • 8.3.2. Latin America
  • 8.3.3. Europe
  • 8.3.4. APAC
  • 8.3.5. MEA
• 8.4. Market Attractiveness By Region

9. North America Aesthetics Combination Therapy Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Basis Point Share (BPS) Analysis By Country
  • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.1.3. Key Regulations
• 9.2. Market Value Forecast By Therapy Type, 2024-2031
  • 9.2.1. BTx-A/Dermal Filler
  • 9.2.2. BTx-A/Laser
  • 9.2.3. Laser/Topical Drug
  • 9.2.4. Laser/Radiofrequency
  • 9.2.5. Dermal Filler/Topical Drug
  • 9.2.6. Others
• 9.3. Market Value Forecast By Application, 2024-2031
  • 9.3.1. Hair Removal
  • 9.3.2. Tattoo Removal
  • 9.3.3. Skin Resurfacing
  • 9.3.4. Scar Removal
  • 9.3.5. Others
• 9.4. Market Value Forecast By End Use, 2024-2031
  • 9.4.1. Hospitals
  • 9.4.2. Ambulatory Surgical Centers
  • 9.4.3. Dermatology Clinics
• 9.5. Market Value Forecast By Country, 2024-2031
  • 9.5.1. US
  • 9.5.2. Canada
• 9.6. Market Attractiveness Analysis
  • 9.6.1. By Therapy Type
  • 9.6.2. By Application
  • 9.6.3. By End Use
  • 9.6.4. By Country
• 9.7. Prominent Trends
• 9.8. Drivers and Restraints: Impact Analysis

10. Latin America Aesthetics Combination Therapy Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Basis Point Share (BPS) Analysis By Country
  • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.1.3. Key Regulations
• 10.2. Market Value Forecast By Therapy Type, 2024-2031
  • 10.2.1. BTx-A/Dermal Filler
  • 10.2.2. BTx-A/Laser
  • 10.2.3. Laser/Topical Drug
  • 10.2.4. Laser/Radiofrequency
  • 10.2.5. Dermal Filler/Topical Drug
  • 10.2.6. Others
• 10.3. Market Value Forecast By Application, 2024-2031
  • 10.3.1. Hair Removal
  • 10.3.2. Tattoo Removal
  • 10.3.3. Skin Resurfacing
  • 10.3.4. Scar Removal
  • 10.3.5. Others
• 10.4. Market Value Forecast By End Use, 2024-2031
  • 10.4.1. Hospitals
  • 10.4.2. Ambulatory Surgical Centers
  • 10.4.3. Dermatology Clinics
• 10.5. Market Value Forecast By Country, 2024-2031
  • 10.5.1. Brazil
  • 10.5.2. Mexico
  • 10.5.3. Rest of Latin America
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Therapy Type
  • 10.6.2. By Application
  • 10.6.3. By End Use
  • 10.6.4. By Country
• 10.7. Prominent Trends
• 10.8. Drivers and Restraints: Impact Analysis

11. Europe Aesthetics Combination Therapy Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Basis Point Share (BPS) Analysis By Country
  • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.1.3. Key Regulations
• 11.2. Market Value Forecast By Therapy Type, 2024-2031
  • 11.2.1. BTx-A/Dermal Filler
  • 11.2.2. BTx-A/Laser
  • 11.2.3. Laser/Topical Drug
  • 11.2.4. Laser/Radiofrequency
  • 11.2.5. Dermal Filler/Topical Drug
  • 11.2.6. Others
• 11.3. Market Value Forecast By Application, 2024-2031
  • 11.3.1. Hair Removal
  • 11.3.2. Tattoo Removal
  • 11.3.3. Skin Resurfacing
  • 11.3.4. Scar Removal
  • 11.3.5. Others
• 11.4. Market Value Forecast By End Use, 2024-2031
  • 11.4.1. Hospitals
  • 11.4.2. Ambulatory Surgical Centers
  • 11.4.3. Dermatology Clinics
• 11.5. Market Value Forecast By Country, 2024-2031
  • 11.5.1. UK
  • 11.5.2. France
  • 11.5.3. Germany
  • 11.5.4. Italy
  • 11.5.5. Spain
  • 11.5.6. Russia
  • 11.5.7. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Therapy Type
  • 11.6.2. By Application
  • 11.6.3. By End Use
  • 11.6.4. By Country
• 11.7. Prominent Trends
• 11.8. Drivers and Restraints: Impact Analysis

12. APAC Aesthetics Combination Therapy Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Basis Point Share (BPS) Analysis By Country
  • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.1.3. Key Regulations
• 12.2. Market Value Forecast By Therapy Type, 2024-2031
  • 12.2.1. BTx-A/Dermal Filler
  • 12.2.2. BTx-A/Laser
  • 12.2.3. Laser/Topical Drug
  • 12.2.4. Laser/Radiofrequency
  • 12.2.5. Dermal Filler/Topical Drug
  • 12.2.6. Others
• 12.3. Market Value Forecast By Application, 2024-2031
  • 12.3.1. Hair Removal
  • 12.3.2. Tattoo Removal
  • 12.3.3. Skin Resurfacing
  • 12.3.4. Scar Removal
  • 12.3.5. Others
• 12.4.Market Value Forecast By End Use, 2024-2031
  • 12.4.1. Hospitals
  • 12.4.2. Ambulatory Surgical Centers
  • 12.4.3. Dermatology Clinics
• 12.5. Market Value Forecast By Country, 2024-2031
  • 12.5.1. Japan
  • 12.5.2. China
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. ASEAN
  • 12.5.6. Rest of APAC
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Therapy Type
  • 12.6.2. By Application
  • 12.6.3. By End Use
  • 12.6.4. By Country
• 12.7. Prominent Trends
• 12.8. Drivers and Restraints: Impact Analysis

13. MEA Aesthetics Combination Therapy Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Basis Point Share (BPS) Analysis By Country
  • 13.1.2. Y-o-Y Growth Projections By Country
  • 13.1.3. Key Regulations
• 13.2. Market Value Forecast By Therapy Type, 2024-2031
  • 13.2.1. BTx-A/Dermal Filler
  • 13.2.2. BTx-A/Laser
  • 13.2.3. Laser/Topical Drug
  • 13.2.4. Laser/Radiofrequency
  • 13.2.5. Dermal Filler/Topical Drug
  • 13.2.6. Others
• 13.3. Market Value Forecast By Application, 2024-2031
  • 13.3.1. Hair Removal
  • 13.3.2. Tattoo Removal
  • 13.3.3. Skin Resurfacing
  • 13.3.4. Scar Removal
  • 13.3.5. Others
• 13.4. Market Value Forecast By End Use, 2024-2031
  • 13.4.1. Hospitals
  • 13.4.2. Ambulatory Surgical Centers
  • 13.4.3. Dermatology Clinics
• 13.5. Market Value Forecast By Country, 2024-2031
  • 13.5.1. GCC Countries
  • 13.5.2. South Africa
  • 13.5.3. North Africa
  • 13.5.4. Rest of MEA
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Therapy Type
  • 13.6.2. By Application
  • 13.6.3. By End Use
  • 13.6.4. By Country
• 13.7. Prominent Trends
• 13.8. Drivers and Restraints: Impact Analysis

14. Competition Landscape

• 14.1. Competition Dashboard
• 14.2. Market Share Analysis By Company (2024)
• 14.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 14.3.1. Alma Lasers Ltd.
  • 14.3.2. Lumenis Ltd.
  • 14.3.3. Cynosure Inc.
  • 14.3.4. Valeant Pharmaceutical International, Inc.
  • 14.3.5. Galderma S.A.
  • 14.3.6. Anika Therapeutics, Inc.
  • 14.3.7. Speciality European Pharma
  • 14.3.8. Merz Pharma GmbH & Co. KGaA
  • 14.3.9. Cutera, Inc
  • 14.3.10. Allergan
  • 14.3.11. Syneron Medical Ltd

15. Assumptions and Acronyms Used

16. Research Methodology

관련자료